A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non-Small Cell Lung Cancer with a KRAS Mutation

Anne-Marie C. Dingemans, Wouter W. Mellema, Harry J. M. Groen, Atie van Wijk, Sjaak A. Burgers, Peter W. A. Kunst, Erik Thunnissen, Danielle A. M. Heideman, Egbert F. Smit*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)743-751
JournalClinical Cancer Research
Volume19
Issue number3
DOIs
Publication statusPublished - 1 Feb 2013

Cite this